D04.112

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds Chronic skin damage and irritation Age-related changes in skin cells Fair skin type with less melanin protection against UV rays History of skin cancers or precancerous skin conditions Immunosuppression or weakened immune system Genetic predisposition

Key Symptoms: Appearance of a persistent, scaly, or cracked lesion on the eyelid A small bump or growth that may be red or white Lesion that may look like a sore that does not heal Changes in skin color or texture around the eyelid In some cases, a somewhat rough or waxy lesion Possible sensation of numbness or discomfort in the affected area

Diagnosis Path: The diagnosis involves a thorough eye and skin examination by a healthcare professional. To confirm the presence of carcinoma in situ, a biopsy of the lesion is performed, where a tissue sample is collected and analyzed under a microscope. Additional imaging studies may be utilized if there is suspicion of deeper involvement or spread, although in situ lesions are typically confined to the skin surface.

Treatment Protocols: Treatment options focus on removing or destroying the abnormal cells while preserving the function and appearance of the eyelid. Common approaches include: - **Surgical excision:** Carefully removing the lesion with clear margins to ensure complete removal. - **Cryotherapy:** Freezing the lesion with liquid nitrogen to destroy abnormal cells. - **Topical chemotherapy:** Application of medicated creams to target abnormal cell growth. - **Photodynamic therapy:** Using light-sensitive compounds and light exposure to destroy affected cells. Follow-up monitoring is essential to detect any recurrence or progression, and additional treatments may be necessary if the lesion recurs or is found to be invasive. Generally, early detection and treatment of carcinoma in situ of the eyelid can lead to favorable outcomes and minimize the risk of invasion into deeper tissues or adjacent structures.